A systematic review assessing the potential use of cystatin c as a biomarker for kidney disease in people living with HIV on antiretroviral therapy.

MLA

Hanser, Sidney, et al. “A Systematic Review Assessing the Potential Use of Cystatin c as a Biomarker for Kidney Disease in People Living with HIV on Antiretroviral Therapy.” Frontiers in Medicine, Apr. 2024, pp. 1–9. EBSCOhost, https://doi.org/10.3389/fmed.2024.1295217.

APA

Hanser, S., Choshi, J., Mokoena, H., Mabhida, S. E., Mchiza, Z. J. R., Moetlediwa, M. T., Muvhulawa, N., Nkambule, B. B., Ndwandwe, D., Nqebelele, U., Kengne, A. P., & Dludla, P. V. (2024). A systematic review assessing the potential use of cystatin c as a biomarker for kidney disease in people living with HIV on antiretroviral therapy. Frontiers in Medicine, 1–9. https://doi.org/10.3389/fmed.2024.1295217

Chicago

Hanser, Sidney, Joel Choshi, Haskly Mokoena, Sihle E. Mabhida, Zandile J. R. Mchiza, Marakiya T. Moetlediwa, Ndivhuwo Muvhulawa, et al. 2024. “A Systematic Review Assessing the Potential Use of Cystatin c as a Biomarker for Kidney Disease in People Living with HIV on Antiretroviral Therapy.” Frontiers in Medicine, April, 1–9. doi:10.3389/fmed.2024.1295217.